IRADIMED CORP - Common Stock (IRMD)

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock
Shares outstanding
12,733,410
Total 13F shares
4,999,149
Share change
+124,267
Total reported value
$230,849,125
Price per share
$46.21
Number of holders
95
Value change
+$7,127,231
Number of buys
51
Number of sells
31

Institutional Holders of IRADIMED CORP - Common Stock (IRMD) as of Q4 2021

As of 31 Dec 2021, IRADIMED CORP - Common Stock (IRMD) was held by 95 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,999,149 shares. The largest 10 holders included Nine Ten Capital Management LLC, RENAISSANCE TECHNOLOGIES LLC, Soleus Capital Management, L.P., BlackRock Inc., VANGUARD GROUP INC, Russell Investments Group, Ltd., Ranger Investment Management, L.P., RK Capital Management, LLC, RICE HALL JAMES & ASSOCIATES, LLC, and RESOURCE CONSULTING GROUP INC. This page lists 95 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.